Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Shanghai Argo Unveils Multiple RNAi Licensing Agreements and Establishes Strategic Collaborations with Novartis
Monday, January 08, 2024Shanghaibased biotechnology firm Argo Biopharmaceutical Co Ltd has recently disclosed two exclusive license and collaboration pacts with Novartis PHARMA AG In the initial agreement
Isomorphic Labs and Novartis Establish Strategic Collaboration for Multi-Target Research
Monday, January 08, 2024Isomorphic Labs a digital biology company specializing in advancing drug discovery through artificial intelligence has revealed a strategic research collaboration with Novartis aimed at identifying small molecule therapeutics
Novartis Announces the Acquisition of Sanreno Therapeutics in a Significant Transaction Aimed at Advancing Innovative Treatments for Kidney Disease
Saturday, January 06, 2024SanReno Therapeutics a clinicalstage company dedicated to the discovery development and commercialization of innovative therapies for kidney diseases has been acquired by Novartis a global pharmaceutical company
Praxis Precision Medicines and Tenacia Biotechnology Have Entered Into a Licensing and Collaboration Agreement for Ulixacaltamide in the Greater China Region
Saturday, January 06, 2024Praxis Precision Medicines Inc has entered into an exclusive collaboration and license agreement with Tenacia Biotechnology Company Ltd a clinicalstage biopharmaceutical company
Avenzo Therapeutics Licenses ARTS-021, a Clinical Stage CDK2 Inhibitor from Allorion
Friday, January 05, 2024Avenzo Therapeutics Inc recently announced an exclusive licensing agreement with Allorion Therapeutics Inc for the global development and commercialization of AVZO a potential bestinclass
Jiangsu Vcare Submits Non-Disclosure Agreement (NDA) for Vicagrel Capsules to US FDA
Friday, January 05, 2024Jiangsu Vcare PharmaTech Co Ltd has achieved a significant milestone by successfully submitting a New Drug Application to the US Food and Drug Administration for its innovative drug
IASO BIO and Umoja Biopharma Establish a Novel Partnership for Advancing Ex Vivo and In Vivo Cell and Gene Therapies
Thursday, January 04, 2024IASO Biotherapeutics and Umoja Biopharma Inc have recently announced a strategic collaboration to advance the development and commercialization of innovative cell and gene therapies
OBI-992 Secures FDA Approval to Commence Phase I/II Clinical Trials
Thursday, January 04, 2024Taiwans Halogen Biotech has announced the independent development of a new antibodydrug complex drug OBI targeting TROP The US Food and Drug Administration has granted approval for a Phase III clinical trial to evaluate its safety and efficacy
MediLink Therapeutics and Roche Establish Worldwide Partnership and License Agreement for the Development of Advanced Oncology Antibody Drug Conjugate
Wednesday, January 03, 2024MediLink Therapeutics also known as MediLink has recently disclosed a global collaboration and licensing agreement with Roche for the development of a new antibodydrug conjugate candidate
CGBio's 'NOVOSIS PUTTY' Attains FDA 'Breakthrough Device Designation,' Paving the Way for Expedited Entry into the US Market
Wednesday, January 03, 2024CGBio under the leadership of CEO Hyun Seung Yu a South Korean bioregenerative medicine company announced on the nd that its advanced bone substitute material NOVOSIS PUTTY has received
